527 related articles for article (PubMed ID: 27557671)
1. Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs.
Pereira RO; Pelisson E Silva TCC; de Oliveira Ferreira A; Brandao MAF; Raposo NRB; Polonini HC
Curr Drug Deliv; 2017; 14(4):516-520. PubMed ID: 27557671
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the transdermal absorption of nimesulide from three commercially available gel formulations.
Dayal P; Kanikkannan N; Singh A; Sing M
Drug Dev Ind Pharm; 2002 Mar; 28(3):297-304. PubMed ID: 12026222
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ultrasound Intensity and Mode on Piroxicam Transport Across Three-Dimensional Skin Equivalent Epiderm™.
Alarjah MA
Recent Pat Drug Deliv Formul; 2020; 14(1):75-83. PubMed ID: 32106808
[TBL] [Abstract][Full Text] [Related]
4. Enhancing effects of fatty acids on piroxicam permeation through rat skins.
Shin SC; Shin EY; Cho CW
Drug Dev Ind Pharm; 2000 May; 26(5):563-6. PubMed ID: 10789070
[TBL] [Abstract][Full Text] [Related]
5. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
[TBL] [Abstract][Full Text] [Related]
6. Permeation Efficacy of a Transdermal Vehicle with Steroidal Hormones and Nonsteroidal Anti-inflammatory Agents as Model Drugs.
Junqueira LA; Polonini H; Loures S; Raposo NRB; Ferreira AO; Brandão MAF
Curr Drug Deliv; 2019; 16(2):136-141. PubMed ID: 30360741
[TBL] [Abstract][Full Text] [Related]
7. Is Vitamin D
D'Angelo Costa GM; Sales de Oliveira Pinto CA; Rodrigues Leite-Silva V; Rolim Baby A; Robles Velasco MV
AAPS PharmSciTech; 2018 Jul; 19(5):2418-2425. PubMed ID: 29869312
[TBL] [Abstract][Full Text] [Related]
8. Effect of microneedle roller on promoting transdermal absorption of crossbow-medicine liquid via transdermal administration of Traditional Chinese Medicine and the safety of crossbow-medicine needle therapy: An experimental study.
Luo H; Zan F; Cui J
J Ethnopharmacol; 2023 Dec; 317():116751. PubMed ID: 37295573
[TBL] [Abstract][Full Text] [Related]
9. Umbilical therapy for promoting transdermal delivery of topical formulations: Enhanced effect and underlying mechanism.
Yang C; Peng X; Shi Y; Zhang Y; Feng M; Tian Y; Zhang J; Cen S; Li Z; Dai X; Jing Z; Shi X
Int J Pharm; 2024 Mar; 652():123834. PubMed ID: 38262583
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
[TBL] [Abstract][Full Text] [Related]
11. Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application.
Polonini H; Ferreira AO; Dijkers E
Int J Pharm Compd; 2021; 25(5):422-426. PubMed ID: 34623968
[TBL] [Abstract][Full Text] [Related]
12. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
[TBL] [Abstract][Full Text] [Related]
13. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers.
Alves MP; Scarrone AL; Santos M; Pohlmann AR; Guterres SS
Int J Pharm; 2007 Aug; 341(1-2):215-20. PubMed ID: 17482392
[TBL] [Abstract][Full Text] [Related]
14. Investigation of pH Influence on Skin Permeation Behavior of Weak Acids Using Nonsteroidal Anti-Inflammatory Drugs.
Chantasart D; Chootanasoontorn S; Suksiriworapong J; Li SK
J Pharm Sci; 2015 Oct; 104(10):3459-70. PubMed ID: 26213208
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of Eudragit
Chantasart D; Tocanitchart P; Wongrakpanich A; Teeranachaideekul V; Junyaprasert VB
Pharm Dev Technol; 2018 Oct; 23(8):771-779. PubMed ID: 28406344
[TBL] [Abstract][Full Text] [Related]
16. Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.
Nada AH; Zaghloul AA; Hedaya MM; Khattab IS
Acta Pharm; 2014 Sep; 64(3):299-309. PubMed ID: 25296676
[TBL] [Abstract][Full Text] [Related]
17. Sensitive LC determination of piroxicam after in vitro transdermal permeation studies.
Doliwa A; Santoyo S; Campanero MA; Ygartua P
J Pharm Biomed Anal; 2001 Nov; 26(4):531-7. PubMed ID: 11516903
[TBL] [Abstract][Full Text] [Related]
18. Gellan Nanohydrogels: Novel Nanodelivery Systems for Cutaneous Administration of Piroxicam.
Musazzi UM; Cencetti C; Franzé S; Zoratto N; Di Meo C; Procacci P; Matricardi P; Cilurzo F
Mol Pharm; 2018 Mar; 15(3):1028-1036. PubMed ID: 29366318
[TBL] [Abstract][Full Text] [Related]
19. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs.
Lee WR; Shen SC; Lai HH; Hu CH; Fang JY
J Control Release; 2001 Jul; 75(1-2):155-66. PubMed ID: 11451505
[TBL] [Abstract][Full Text] [Related]
20. [Development of Transdermal Formulation Based on Nanotechnology and Elucidation of Its Drug Delivery Pathways].
Otake H; Nagai N
Yakugaku Zasshi; 2024; 144(5):505-510. PubMed ID: 38692925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
